Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Effect of PEMF on recovery after ACL reconstruction with hamstring autograft

Official title: Effect of Pulsed Electromagnetic Fields on Promoting Hamstring Muscle Strength After Anterior Cruciate Ligament Reconstruction With Hamstring Autograft: A Double-Blind, Placebo-Controlled, Randomised Clinical Trial

Run by Chinese University of Hong Kong · NCT06464705 · Data updated 2026-11-12

This study is testing if pulsed electromagnetic field therapy can help people recover faster and regain strength in their hamstring after ACL surgery using their own hamstring tendon.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations1 site (Shatin)
StatusRecruiting
StartedJune 13, 2024
Main results expectedMarch 31, 2027
Study endsMarch 31, 2027
Registry record updatedAugust 12, 2026
Trial IDNCT06464705 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who are undergoing their first ACL reconstruction with hamstring autograft and have a hamstring strength deficit.

Probably not a fit

Patients with prior knee injuries, significant comorbidities, or those who cannot provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the impact of pulsed electromagnetic field (PEMF) therapy on patients recovering from anterior cruciate ligament (ACL) reconstruction using hamstring tendon autograft. The focus is on enhancing muscle cell activity and accelerating recovery of hamstring strength, which is often compromised after surgery. Participants will be randomly assigned to receive either PEMF treatment or a placebo, with assessments of hamstring strength conducted at 4 months post-surgery. The goal is to determine if PEMF can improve outcomes related to muscle strength and overall knee function.

Why it matters

Potential benefit: If successful, this treatment could significantly enhance recovery and strength in patients after ACL reconstruction, potentially reducing the risk of future injuries.

How similar studies have gone: While PEMF therapy has shown promise in enhancing muscle recovery in other contexts, this specific application in ACL reconstruction is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male and female with age ≥ 18 years at the time of surgery
2. First ACLR with HT autograft
3. Both knees without a history of injury/prior surgery
4. LSI for hamstring strength \<85% of contralateral leg at 4-month isokinetic assessment (70)
5. Voluntarily agreed to participate and signed the informed consent form

Exclusion Criteria:

1. Any concomitant bone fracture, major meniscus injury or full-thickness chondral injuries requiring altered rehabilitation program post-op
2. Preoperative radiographic signs of arthritis
3. Other associated injuries (fractures and other ligament involvement such as neurovascular bundles injury)
4. Patient with a pacemaker, an implantable defibrillator, neurosurgical clips, a neurostimulator, cochlear implant, a stent, an insulin pump
5. Pregnant or breastfeeding
6. Inability to give informed consent

Where it's running

  • Prince of Wales Hospital
    Shatin, Hong Kong
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.